Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Low-income cost-sharing subsidies do not apply to the copay either
According to FDA prescribing information, gastrointestinal side effects are typically most pronounced during dose initiation and escalation, and they often diminish over time as the body adapts to the medication
Tirzepatide, which activates both GLP-1 and GIP receptors, may produce different effects compared to pure GLP-1 agonists
You may be a good candidate for GLP-1 treatment if you: Have been diagnosed with type 2 diabetes Have obesity, or a body mass index (BMI) of 30 or higher Have overweight (a BMI of 25 to 29.9) plus at least one weight-related condition, such as heart disease or type 2 diabetes Ultimately, the decision to start treatment for weight loss is up to you and your healthcare provider
Tirzepatides dual mechanism of action that may help maximize weight loss Chances are someone you know is taking a GLP-1 medication
Retatrutide itself is still being studied, but approved incretin therapies can require careful glucose monitoring when used with diabetes medications that lower blood sugar
US$ 21.68
US$ 29.69
US$ 24.83
US$ 25.75
